According to the latest industry analysis by Future Market Insights, the global obesity-diabetes drugs market valued at approximately USD 56,739.0 million in 2024. The market is projected to exhibit moderate growth with a compound annual growth rate (CAGR) of 5.6% over the forecast period, reaching an estimated valuation of USD 97,567.4 million by 2034. https://www.fmiblog.com/2024/08/08/obesity-diabetes-drugs-market-sales/